A rating of 87 puts Zynerba Pharmaceuticals Inc (ZYNE) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. Zynerba Pharmaceuticals Inc's score of 87 means it scores higher than 87% of stocks in the industry. Zynerba Pharmaceuticals Inc also received an overall rating of 44, putting it above 44% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 141 out of the 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 44 would rank higher than 44 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Zynerba Pharmaceuticals Inc Stock Today?
Zynerba Pharmaceuticals Inc (ZYNE) stock is trading at $4.36 as of 10:48 AM on Thursday, May 13, a gain of $0.12, or 2.83% from the previous closing price of $4.24. The stock has traded between $4.25 and $4.51 so far today. Volume today is low. So far 487,755 shares have traded compared to average volume of 1,493,580 shares.
Click Here to get the full Stock Score Report on Zynerba Pharmaceuticals Inc (ZYNE) Stock.
